Trials / Completed
CompletedNCT03545724
Effectiveness & Safety of Neofitoroid® in Hemorrhoidal Disease
Prospective, Single Arm, Open Study to Evaluate the Effect of NeoFitoroid® in Reducing Symptoms in Patients With Hemorrhoidal Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Aboca Spa Societa' Agricola · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of the effect and safety of NeoFitoroid® in reducing symptoms in patients with hemorrhoidal disease.
Detailed description
Evaluation of the effect and safety of NeoFitoroid® in relieving discomfort symptom after 10 days of treatment compared to baseline (pretreatment). The study duration per patient is 31 days (visit 1 + 10 days treatment + 20 days follow-up).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Neofitoroid® | NeoFitoroid® forms a protective barrier mucosa and on perianal region that can aid the physiological process of healing. |
Timeline
- Start date
- 2018-02-07
- Primary completion
- 2018-11-19
- Completion
- 2019-05-16
- First posted
- 2018-06-04
- Last updated
- 2019-05-30
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT03545724. Inclusion in this directory is not an endorsement.